[Thymoleptic activity of a new antidepressive drug benzoxazone (FI 6654). Preliminary clinico-therapeutic observations].
D000275:Adjustment Disorders / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D004569:Electroencephalography; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010078:Oxazines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales
D000928:Antidepressive Agents; D010078:Oxazines; D007099:Imipramine
Sull'attività timolettica di un nuovo farmaco antidepressivo: il benzocazone (FI 6654). Prime osservazioni clinico-terapeutiche.